Families desperately need support too.
Searching for Solutions
This study of US youths found that year-to-year elevations in self-reported PSMU were directly associated with ADHD symptoms during mid-adolescence, particularly among males; reverse associations of ADHD symptoms with later PSMU were small in magnitude and sporadic.
This PhenX Toolkit SURWG process resulted in a new Substance Use Recovery Specialty Collection of recommended protocols with specific multidimensional applicability.
By gaining an understanding of the populations benefiting from these services, breadth of services provided, and the costs required to address this barrier to care, we may more effectively inform decision-makers on the resources needed to link and retain individuals in treatment.
This study illuminated reasons for not carrying naloxone, primarily related to stigma, discomfort with administration, or a lack of awareness/risk perception for an opioid-related overdose.
This study found no evidence any individual route of administration was associated with higher heroin overdose risk; instead, use of a single route tended to be associated with lower overdose odds than use of multiple routes.
Results suggest acceptability of a device for overdose detection and naloxone administration among PWUO and the addiction workforce, with more acceptability for a wearable versus implantable device.
In this study of pharmacies across the US, same-day naloxone availability and price remained uneven following OTC approval.
Among adults with AUD and T2D or obesity, initiation of newer GLP-1 RAs was associated with a lower observed risk of alcohol-related hospitalisation.
This paper briefly outlines the scientific rationale for brain circuit–based care, reviews the evidence for key interventions, and identifies barriers to implementation within public systems.
GTMRx submitted comments on NCQA’s Advanced Primary Care (APC) Accreditation standards, urging stronger recognition of medication optimization as a core component of high-quality, team-based primary care. AAPP is a supporter of GTMRx. The comments recommend incorporating comprehensive medication management throughout the standards and highlight the value of integrating clinical pharmacists into primary care teams to improve patient outcomes, safety, and overall healthcare value.
The study found that compared to 2014, burnout is higher among pharmacy practice faculty.
The FDA has approved centanafadine (Simtriyo), the first and only norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI) for the treatment of ADHD in adults and children ages 6 and older weighing at least 20 kg. The approval was based on four Phase 3 clinical trials showing statistically significant and clinically meaningful improvements in ADHD symptoms. Centanafadine is expected to become available later this year following U.S. Drug Enforcement Administration (DEA) scheduling.
No summary available
Before we turn our attention fully to the months ahead, I want to take a moment to look back at our wonderful Annual Meeting this past spring in Bellevue, Washington. The Pacific Northwest welcomed 713 attendees in person, with another 236 joining virtually. More than half of attendees were BCPPs, and we had representation from 27 states and five countries. We were also thrilled to welcome 144 students, whose enthusiasm and engagement brought a ton of energy to the meeting!
On July 27, the Substance Abuse and Mental Health Services Administration (SAMHSA) released the 2025 National Survey on Drug Use and Health (NSDUH) results. This survey provides insights into the experiences of U.S. residents experiencing mental health and substance use disorders.
This report presents data from the 2025 RAND Psychedelics Survey regarding the use of specific psychedelic substances and policy preferences among U.S. veterans.
Describes CPP independent B-MOUD prescribing within VHA as an effective practice that could model pharmacist care in other large health care systems.
This edition reflects the considerable growth of the evidence base since the publication of 2019 guidelines and expands the scope of guidance on dementia risk reduction.
Among hospitalized adult males with MUD, adjunctive mirtazapine significantly reduced craving over 8 weeks.
This guideline focuses on the identification, diagnosis, treatment, and promotion of recovery for patients with StUD, stimulant intoxication, and stimulant withdrawal.
In this study of buprenorphine-naloxone vs XR naltrexone, initiating buprenorphine-naloxone after MMOW discharge was associated with a lower risk of nonfatal opioid overdose at 24 weeks than initiating XR naltrexone, but a similar risk of all-cause mortality.
SMAs appear feasible and acceptable for addiction care and may support treatment retention and patient experience.
The widely varying experiences of people in the United States participating in mandated substance use disorder treatment programs underscore the difficulty of rendering sweeping conclusions about the benefits and harms of mandated treatment and highlight the need to calibrate programs and policies to meet the specific needs and interests of different groups facing mandates.
In this survey study, an appreciable portion of adolescents were not aware of the dangers of fentanyl use.